Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
proton cotransporter\; mediates the uptake of neurotransmitters into vesicles [RGD, Feb 2006].. Additionally we are shipping SV2B Proteins (8) and many more products for this protein.
Showing 10 out of 35 products:
Human Polyclonal SV2B Primary Antibody for ICC, IP - ABIN1742258
Boido, Farisello, Cesca, Ferrea, Valtorta, Benfenati, Baldelli: Cortico-hippocampal hyperexcitability in synapsin I/II/III knockout mice: age-dependency and response to the antiepileptic drug levetiracetam. in Neuroscience 2010
Show all 11 references for ABIN1742258
Human Monoclonal SV2B Primary Antibody for ICC, IP - ABIN1742257
Dagar, Nagar, Goel, Cherukuri, Dhingra: Loss of photoreceptors results in upregulation of synaptic proteins in bipolar cells and amacrine cells. in PLoS ONE 2014
Show all 2 references for ABIN1742257
To study the role of SV2B in maintaining the podocyte function and to better understand the function of the neuron-like vesicle expressing SV2B in the podocyte, we analyzed them with SV2B knockout (KO) mice.
Glutamatergic & GABAergic transmission are unaffected by deletion of the SV2B protein. Additional deletion of SV2B does not affect the electrophysiological phenotype of SV2A (show SV2A Antibodies) deletion.
Loss of synaptic vesicle glycoprotein 2b is associated with inhibition of tetanus neurotoxin into central neurons.
These results indicate that SV2 (show SV2A Antibodies) performs at least two actions at the synapse that contribute to neurotransmitter release.
SV2 (show SV2A Antibodies) controls key aspects of synaptic functionality via its ability to regulate presynaptic Ca(2 (show CA2 Antibodies)+).
SV2B-synaptotagmin 1 (show SYT1 Antibodies) complex is involved in the regulation of synaptotagmin 1 (show SYT1 Antibodies) stability and/or trafficking
SV2 (show SV2A Antibodies) action modulates synaptic networks by ensuring that low-frequency neurotransmission is faithfully conveyed.
findings show that botulinum neurotoxin (BoNT/A) enters neurons by binding to the synaptic vesicle protein SV2 (show SV2A Antibodies) (isoforms A, B, and C);SV2 (show SV2A Antibodies) acts as the protein receptor for BoNT/A
Data demonstrate that glycosylated SV2A (show SV2A Antibodies) and SV2B act in conjunction with gangliosides to mediate the entry of BoNT/E into neurons.
SV2B contributes to the modulation of synaptic vesicle exocytosis and plays a significant role in regulating synaptic protein content
In classical mesial temporal sclerosis 1A, the expression of SV2 (show SV2A Antibodies) isoforms is altered with a marked decrease of SV2B paralleling synaptic loss.
Synaptic vesicle protein 2 (show SV2A Antibodies) binds adenine nucleotides
proton cotransporter\; mediates the uptake of neurotransmitters into vesicles
synaptic vesicle protein 2B homolog
, synaptic vesicle glycoprotein 2B
, synaptic vesicle glycoprotein 2B-like
, synaptic vesicle protein 2B